Form 4 for MLYS Mineralys Therapeutics, Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0001933414-25-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Gold Alexander M | Dir | S - Sale+OE | $45.45 | -34.7K | 5,000 | -87% | -$1.58M |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Gold Alexander M | Dir | M - OptEx | $10.92 | +34.7K | 15.0K | New | +$378.6K |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Gold Alexander M | Dir | M - OptEx | $0.00 | -34.7K | 34.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-11 | S | D | 5,000 | $47.08 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-12 | M | A | 6,933 | $10.20 | 6,933 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-12 | S | D | 5,000 | $46.50 | 1,933 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-12 | S | D | 1,933 | $47.28 | 0 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-13 | M | A | 2,742 | $10.20 | 2,742 | D | — | — | |
| 6 | Common | Common Stock | 2025-11-13 | M | A | 10,000 | $12.69 | 12,742 | D | — | — | |
| 7 | Common | Common Stock | 2025-11-13 | S | D | 12,742 | $46.50 | 0 | D | — | — | |
| 8 | Common | Common Stock | 2025-11-11 | M | A | 15,000 | $10.20 | 15,000 | D | — | — | |
| 9 | Common | Common Stock | 2025-11-11 | S | D | 10,000 | $42.43 | 5,000 | D | — | — | |
| 10 | Derivative | Stock Option | 2025-11-13 | M | D | 2,742 | $0.00 | 8,225 | D | $10.20 · — to 2035-02-13 | 2,742 Common Stock | (F1) The stock option vests in 12 monthly installments following the date of grant. |
| 11 | Derivative | Stock Option | 2025-11-12 | M | D | 6,933 | $0.00 | 10,967 | D | $10.20 · — to 2035-02-13 | 6,933 Common Stock | (F1) The stock option vests in 12 monthly installments following the date of grant. |
| 12 | Derivative | Stock Option | 2025-11-11 | M | D | 15,000 | $0.00 | 17,900 | D | $10.20 · — to 2035-02-13 | 15,000 Common Stock | (F1) The stock option vests in 12 monthly installments following the date of grant. |
| 13 | Derivative | Stock Option | 2025-11-13 | M | D | 10,000 | $0.00 | 34,000 | D | $12.69 · — to 2034-06-13 | 10,000 Common Stock | (F2) The stock option vests in 36 monthly installments beginning on July 13, 2024. |